Elysium Health Launches Longevity Program Waitlist

Elysium Health's TELI program combines personalized biomarker testing with physician-led clinical protocols.

Elysium Health Enters Physician-Led Longevity Medicine

According to a press release distributed by PR Newswire, Elysium Health has officially launched the waitlist for its new, physician-led longevity program called TELI. The company, known for its cellular health supplements, announced that the program marks its transition into personalized clinical services. According to Elysium Health, the TELI initiative is designed to provide participants with direct access to licensed healthcare providers who specialize in longevity medicine, allowing patients to receive tailored clinical assessments and custom prescription protocols.

Personalized Protocols: Customizing NAD+ and Peptides

Elysium Health's official announcement states that the TELI program will offer personalized protocols utilizing intravenous and subcutaneous therapies, specifically targeting cellular NAD+ levels and peptide pathways. Based on clinical evaluations, physicians in the program may prescribe customized regimens that include NAD+ precursors and select peptide therapies such as growth hormone secretagogues. The program aims to optimize metabolic function, support tissue repair, and promote healthy aging by addressing age-related declines in essential coenzymes and cellular signaling molecules, according to preliminary program details.

The Science Behind NAD+ and Growth Hormone Secretagogues

The clinical rationale for the program rests on the growing body of literature surrounding cellular senescence and mitochondrial function. According to researchers, nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme that declines with age, leading to impaired energy production and cellular maintenance. Similarly, peptides like sermorelin may stimulate the pituitary gland to release natural growth hormone, which has been shown to support lean muscle mass and fat metabolism. Elysium Health suggests that combining these therapies under medical supervision could offer synergistic benefits for overall cellular health.

How the TELI Longevity Program Waitlist Works

As reported on the official Elysium Health website, the TELI program is currently in a pre-launch phase, with the newly opened waitlist securing early access for interested individuals. The company indicates that enrollment will be limited during the initial rollout to ensure high-quality care and individualized attention from the medical staff. Participants on the waitlist will be the first to undergo comprehensive telehealth consultations, diagnostic biomarker testing, and subsequent clinical onboarding as spaces become available in late 2026.

Evaluating Modern Alternatives for Metabolic Support

While the TELI program offers a comprehensive approach to cellular aging and peptide therapy, patients seeking specific health outcomes, such as weight reduction, may also consider established telehealth options. Clinicians emphasize that longevity protocols should complement, not replace, fundamental metabolic care. For individuals primarily focused on weight management, FDA-approved medications like semaglutide treatment programs and tirzepatide options remain the standard of care. To determine eligibility for these targeted therapies, individuals can check if they qualify through licensed clinical programs.

This article is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication or treatment.